Offering new hope to patients suffering from prostate cancer, South Korean scientists have claimed that a common hair loss drug used by current President could ward off the risk of this form of cancer by a third. The findings, led by researchers from the Chungbuk National University, revealed that men who take the drug saw their prostate-specific antigen (PSA) levels reduced by one-third, reported last weekend. PSA is a protein linked with a high risk of developing prostate cancer. Previously, a study also linked a drug used to curb greying hair with cancer treatment.
It was originally developed to treat urinary problems in men, works by making the prostate glands smaller. It also reduces the levels of the hormone dihydrotestosterone in participants, known to damage hair follicles. "It's been known for some time that 5-alpha-inhibitors can affect a man's PSA levels and, as a result,…
